Platelet and leukocyte activation, atherosclerosis and inflammation in European and South Asian men

Journal of Thrombosis and Haemostasis

Volumn 5, Issue 10, 2007, Pages 2036-2042

  Dotsenko, O ^a   Chaturvedi, N ^a   McG Thom, S A ^a   Wright, A R ^b   Mayet, J ^c   Shore, A ^c   Schalkwijk, C ^d   Hughes, A D ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

^c PENINSULA MEDICAL SCHOOL   (United Kingdom)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Atherosclerosis; Monocyte; Platelet; Pulse wave velocity

Indexed keywords

C REACTIVE PROTEIN; L SELECTIN; PADGEM PROTEIN;

ADULT; AGED; AORTA ATHEROSCLEROSIS; ARTERY CALCIFICATION; ARTICLE; ASIAN; B SCAN; BINDING SITE; CAROTID ARTERY; COMPLEX FORMATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ETHNICITY; EUROPE; FEMORAL ARTERY; FLOW CYTOMETRY; HUMAN; HYPERTENSION; INFLAMMATION; LEUKOCYTE ACTIVATION; LEUKOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MULTIDETECTOR COMPUTED TOMOGRAPHY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PULSE WAVE; SMOKING; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION;

AGED; ASIA; ASIAN CONTINENTAL ANCESTRY GROUP; ATHEROSCLEROSIS; BLOOD PLATELETS; C-REACTIVE PROTEIN; CAROTID ARTERIES; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; INFLAMMATION; L-SELECTIN; LEUKOCYTES; MALE; MIDDLE AGED; P-SELECTIN;

EID: 34548819350     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2007.02711.x     Document Type: Article

References (43)

1. Libby P. Changing concepts of atherogenesis. J.Intern Med 2000; 247: 349-58.
2. Huo Y, Ley KF. Role of platelets in the development of atherosclerosis. Trends Cardiovasc Med 2004; 14: 18-22.
3. FitzGerald DJ, Roy L, Catella F, Fitzgerald GA. Platelet activation in unstable coronary disease. N Engl J Med 1986; 315: 983-9.
4. Furman MI, Benoit SE, Barnard MR, Valeri CR, Borbone ML, Becker RC, Hechtman HB, Michelson AD. Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J.Am Coll Cardiol 1998; 31: 352-8.
5. Furman MI, Barnard MR, Krueger LA, Fox ML, Shilale EA, Lessard DM, Marchese P, Frelinger AL III, Goldberg RJ, Michelson AD. Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. J.Am Coll Cardiol 2001; 38: 1002-6.
6. Tan KT, Tayebjee MH, Macfadyen RJ, Lip GY, Blann AD. Elevated platelet microparticles in stable coronary artery disease are unrelated to disease severity or to indices of inflammation. Platelets 2005; 16: 368-71.
7. Koyama H, Maeno T, Fukumoto S, Shoji T, Yamane T, Yokoyama H, Emoto M, Shoji T, Tahara H, Inaba M, Hino M, Shioi A, Miki T, Nishizawa Y. Platelet P-selectin expression is associated with atherosclerotic wall thickness in carotid artery in humans. Circulation 2003; 108: 524-9.
8. Shoji T, Koyama H, Fukumoto S, Maeno T, Yokoyama H, Shinohara K, Emoto M, Shoji T, Yamane T, Hino M, Shioi A, Nishizawa Y. Platelet activation is associated with hypoadiponectinemia and carotid atherosclerosis. Atherosclerosis 2006; 188: 190-5.
9. Ruf A, Patscheke H. Flow cytometric detection of activated platelets: comparison of determining shape change, fibrinogen binding, and P-selectin expression. Semin Thromb Hemost 1995; 21: 146-51.
10. Gresele P, Catalano M, Giammarresi C, Volpato R, Termini R, Ciabattoni G, Nenci GG, Davi G. Platelet activation markers in patients with peripheral arterial disease -a prospective comparison of different platelet function tests. Thromb Haemost 1997; 78: 1434-7.
11. McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991; 337: 382-6.
12. Markovitz JH, Kulkarni K, Goldschmidt-Clermont P, Kiefe CI, Rustagi P, Sekar P, Nanda N. Increased platelet activation and fibrinogen in Asian Indians. Potential implications for coronary risk. Eur Heart J 1998; 19: 720-6.
13. Whincup PH, Gilg JA, Papacosta O, Seymour C, Miller GJ, Alberti KG, Cook DG. Early evidence of ethnic differences in cardiovascular risk: Cross sectional comparison of British South Asian and white children. BMJ 2002; 324: 635.
14. McKeigue PM, Marmot MG, Syndercombe Court YD, Cottier DE, Rahman S, Riemersma RA. Diabetes, hyperinsulinaemia and coronary risk factors in Bangladeshis in East London. Br Heart J 1988; 60: 390-6.
15. Wild S, McKeigue P. Cross sectional analysis of mortality by country of birth in England and Wales, 1970-92. BMJ 1997; 314: 705-10.
16. Enas EA, Garg A, Davidson MA, Nair VM, Huet BA, Yusuf S. Coronary heart disease and its risk factors in first-generation immigrant Asian Indians to the United States of America. Indian Heart J 1996; 48: 343-53.
17. Chaturvedi N, Coady E, Mayet J, Wright AR, Shore AC, Byrd S, McG Thom SA, Kooner JS, Schalkwijk CG, Hughes AD. Indian Asian men have less peripheral arterial disease than European men for equivalent levels of coronary disease. Atherosclerosis 2007; 193: 204-12.
18. Bone M. Registration with General Medical Practitioners in Inner London: A Survey Carried Out on Behalf of the Department of Health and Social Security. London: HMSO; 1984.
19. Klinkhardt U, Bauersachs R, Adams J, Graff J, Lindhoff-Last E, Harder S. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease. Clin Pharmacol Ther 2003; 73: 232-41.
20. Rose GA. Chest pain questionnaire. Milbank Mem Fund Q 1965; 43: 32-9.
21. Wendelhag I, Wiklund O, Wikstrand J. Atherosclerotic changes in the femoral and carotid arteries in familial hypercholesterolemia. Ultrasonographic assessment of intima-media thickness and plaque occurrence. Arterioscler Thromb 1993; 13: 1404-11.
22. Tillin T, Chambers J, Malik I, Coady E, Byrd S, Mayet J, Wright AR, Kooner J, Shore A, Thom S, Chaturvedi N, Hughes A. Measurement of pulse wave velocity: Site matters. J.Hypertens 2007; 25: 383-9.
23. Schmitz G, Rothe G, Ruf A, Barlage S, Tschope D, Clemetson KJ, Goodall AH, Michelson AD, Nurden AT, Shankey TV. European Working Group on Clinical Cell Analysis: Consensus protocol for the flow cytometric characterisation of platelet function. Thromb Haemost 1998; 79: 885-96.
24. Michelson AD, Barnard MR, Krueger LA, Valeri CR, Furman MI. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: Studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 2001; 104: 1533-7.
25. Nomura S, Inami N, Iwasaka T, Liu Y. Platelet activation markers, microparticles and soluble adhesion molecules are elevated in patients with arteriosclerosis obliterans: Therapeutic effects by cilostazol and potentiation by dipyridamole. Platelets 2004; 15: 167-72.
26. Farrar DJ, Green HD, Bond MG, Wagner WD, Gobbee RA. Aortic pulse wave velocity, elasticity, and composition in a nonhuman primate model of atherosclerosis. Circ Res 1978; 43: 52-62.
27. Sawabe M, Takahashi R, Matsushita S, Ozawa T, Arai T, Hamamatsu A, Nakahara K, Chida K, Yamanouchi H, Murayama S, Tanaka N. Aortic pulse wave velocity and the degree of atherosclerosis in the elderly: A pathological study based on 304 autopsy cases. Atheroscler 2005; 179: 345-51.
28. Laurent S, Katsahian S, Fassot C, Tropeano AI, Gautier I, Laloux B, Boutouyrie P. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke 2003; 34: 1203-6.
29. Willum-Hansen T, Staessen JA, Torp-Pedersen C, Rasmussen S, Thijs L, Ibsen H, Jeppesen J. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circ 2006; 113: 664-70.
30. Sutton-Tyrrell K, Najjar SS, Boudreau RM, Venkitachalam L, Kupelian V, Simonsick EM, Havlik R, Lakatta EG, Spurgeon H, Kritchevsky S, Pahor M, Bauer D, Newman A. Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circ 2005; 111: 3384-90.
31. Suurkula M, Fagerberg B, Wendelhag I, Agewall S, Wikstrand J. Atherosclerotic disease in the femoral artery in hypertensive patients at high cardiovascular risk. The value of ultrasonographic assessment of intima-media thickness and plaque occurrence. Risk Intervention Study (RIS) Group. Arterioscler Thromb Vasc Biol 1996; 16: 971-7.
32. Megnien JL, Sene V, Jeannin S, Hernigou A, Plainfosse MC, Merli I, Atger V, Moatti N, Levenson J, Simon A. Coronary calcification and its relation to extracoronary atherosclerosis in asymptomatic hypercholesterolemic men. The PCV METRA Group. Circ 1992; 85: 1799-807.
33. Hulthe J, Wikstrand J, Emanuelsson H, Wiklund O, de-Feyter PJ, Wendelhag I. Atherosclerotic changes in the carotid artery bulb as measured by B-mode ultrasound are associated with the extent of coronary atherosclerosis. Stroke 1997; 28: 1189-94.
34. Giral P, Pithois MI, Filitti V, Levenson J, Plainfosse MC, Mainardi C, Simon AC. Risk factors and early extracoronary atherosclerotic plaques detected by three-site ultrasound imaging in hypercholesterolemic men. Prevention Cardio-Vasculaire en Medecine du Travail METRA Group. Arch Intern Med 1991; 151: 950-6.
35. McGill HC Jr, McMahan CA. Determinants of atherosclerosis in the young. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Am J Cardiol 1998; 82: 30T-6T.
36. Kroger K, Kucharczik A, Hirche H, Rudofsky G. Atherosclerotic lesions are more frequent in femoral arteries than in carotid arteries independent of increasing number of risk factors. Angiology 1999; 50: 649-54.
37. McCabe DJ, Harrison P, Mackie IJ, Sidhu PS, Purdy G, Lawrie AS, Watt H, Machin SJ, Brown MM. Increased platelet count and leucocyte-platelet complex formation in acute symptomatic compared with asymptomatic severe carotid stenosis. J.Neurol Neurosurg Psychiatry 2005; 76: 1249-54.
38. Stenberg PE, McEver RP, Shuman MA, Jacques YV, Bainton DF. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J.Cell Biol 1985; 101: 880-6.
39. Michelson AD, Barnard MR, Hechtman HB, MacGregor H, Connolly RJ, Loscalzo J, Valeri CR. In vivo tracking of platelets: Circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci USA 1996; 93: 11877-82.
40. Knight CJ, Panesar M, Wright C, Clarke D, Butowski PS, Patel D, Patrineli A, Fox K, Goodall AH. Altered platelet function detected by flow cytometry. Effects of coronary artery disease and age. Arterioscler Thromb Vasc Biol 1997; 17: 2044-53.
41. McBane RD, Karnicki K, Tahirkheli N, Miller RS, Owen WG. Platelet characteristics associated with coronary artery disease. J.Thromb Haemost 2003; 1: 1296-303.
42. Doruk H, Kaptan K, Saglam M, Ateskan U, Beyan C, Nevruz O, Mas MR, Kutlu M, Kocar IH. The relationship between carotid atherosclerosis and platelet aggregation in elderly. Arch Gerontol Geriatr 2003; 37: 235-9.
43. Shimizu M, Kohara S, Yamamoto M, Ando Y, Haida M, Shinohara Y. Significant relationship between platelet activation and intra-media thickness of the carotid artery in patients with ischemic cerebrovascular disease. Thromb Res 2006; 117: 647-52.